Preventing Crystallization of Phospholipids in Monolayers: A New Approach to Lung‐Surfactant Therapy
- 25 April 2005
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition in English
- Vol. 44 (18) , 2749-2752
- https://doi.org/10.1002/anie.200462978
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Injectable Microbubbles as Contrast Agents for Diagnostic Ultrasound Imaging: The Key Role of PerfluorochemicalsAngewandte Chemie International Edition in English, 2003
- Mikrobläschen als Kontrastmittel für die diagnostische Ultraschall‐Bildgebung: die Schlüsselrolle von PerfluorverbindungenAngewandte Chemie, 2003
- The physics and physiology of lung surfactantsCurrent Opinion in Colloid & Interface Science, 2001
- Oxygen Carriers (“Blood Substitutes”)Raison d'Etre, Chemistry, and Some PhysiologyBlut ist ein ganz besondrer SaftChemical Reviews, 2001
- Effects of Lung Surfactant Proteins, SP-B and SP-C, and Palmitic Acid on Monolayer StabilityBiophysical Journal, 2001
- Lung SurfactantsPublished by Taylor & Francis ,2000
- The role of lipids in pulmonary surfactantBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1998
- Perfluorochemical rescue after surfactant treatment: effect of perflubron dose and ventilatory frequencyJournal of Applied Physiology, 1998
- High-frequency partial liquid ventilation in respiratory distress syndrome: hemodynamics and gas exchangeJournal of Applied Physiology, 1998
- Partial Liquid Ventilation with Perflubron in Premature Infants with Severe Respiratory Distress SyndromeNew England Journal of Medicine, 1996